PP01.29: Long-Term Outcomes with Tepotinib for Clinically Relevant Subgroups of Patients with MET Exon 14 (METex14) Skipping NSCLC in the VISION Study: A ≥3-Year Follow-Up
作者
Paul K. Paik,Roberto Ferrara,Enriqueta Felip,Egbert Frederik Smit,Rémi Veillon,Xiuning Le,Julien Mazières,Alexis Benjamin Cortot,Jo Raskin,Michael Thomas,Niels Reinmuth,James Chih-Hsin Yang,Myung‐Ju Ahn,Jun Zhao,Hiroshi Sakai,Santiago Viteri,Yi-Long Wu,Rolf Bruns,Andreas Johne,Frank Griesinger